CVS HEALTH CORP (1CVS.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:1CVS • US1266501006

62.26 EUR
-6.14 (-8.98%)
Last: Jan 29, 2026, 07:00 PM
Fundamental Rating

4

Taking everything into account, 1CVS scores 4 out of 10 in our fundamental rating. 1CVS was compared to 33 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of 1CVS have multiple concerns. 1CVS scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • 1CVS had positive earnings in the past year.
  • 1CVS had a positive operating cash flow in the past year.
  • In the past 5 years 1CVS has always been profitable.
  • 1CVS had a positive operating cash flow in each of the past 5 years.
1CVS.MI Yearly Net Income VS EBIT VS OCF VS FCF1CVS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.18%, 1CVS is doing worse than 66.67% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 0.64%, 1CVS is doing worse than 69.70% of the companies in the same industry.
  • 1CVS has a Return On Invested Capital (4.90%) which is in line with its industry peers.
  • 1CVS had an Average Return On Invested Capital over the past 3 years of 6.22%. This is in line with the industry average of 5.90%.
Industry RankSector Rank
ROA 0.18%
ROE 0.64%
ROIC 4.9%
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
1CVS.MI Yearly ROA, ROE, ROIC1CVS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • 1CVS has a worse Profit Margin (0.12%) than 66.67% of its industry peers.
  • 1CVS's Profit Margin has declined in the last couple of years.
  • 1CVS has a worse Operating Margin (2.73%) than 69.70% of its industry peers.
  • 1CVS's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 13.88%, 1CVS is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
  • 1CVS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.73%
PM (TTM) 0.12%
GM 13.88%
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-4.91%
1CVS.MI Yearly Profit, Operating, Gross Margins1CVS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

More info and screens

3

2. Health

2.1 Basic Checks

  • 1CVS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, 1CVS has less shares outstanding
  • The number of shares outstanding for 1CVS has been reduced compared to 5 years ago.
  • 1CVS has a worse debt/assets ratio than last year.
1CVS.MI Yearly Shares Outstanding1CVS.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
1CVS.MI Yearly Total Debt VS Total Assets1CVS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

2.2 Solvency

  • 1CVS has an Altman-Z score of 2.24. This is not the best score and indicates that 1CVS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.24, 1CVS is doing good in the industry, outperforming 72.73% of the companies in the same industry.
  • 1CVS has a debt to FCF ratio of 10.46. This is a negative value and a sign of low solvency as 1CVS would need 10.46 years to pay back of all of its debts.
  • 1CVS has a Debt to FCF ratio of 10.46. This is comparable to the rest of the industry: 1CVS outperforms 57.58% of its industry peers.
  • 1CVS has a Debt/Equity ratio of 0.85. This is a neutral value indicating 1CVS is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.85, 1CVS is in line with its industry, outperforming 54.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 10.46
Altman-Z 2.24
ROIC/WACC0.61
WACC8.02%
1CVS.MI Yearly LT Debt VS Equity VS FCF1CVS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 0.83 indicates that 1CVS may have some problems paying its short term obligations.
  • 1CVS has a Current ratio (0.83) which is comparable to the rest of the industry.
  • A Quick Ratio of 0.63 indicates that 1CVS may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.63, 1CVS is in line with its industry, outperforming 42.42% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.63
1CVS.MI Yearly Current Assets VS Current Liabilites1CVS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

More info and screens

4

3. Growth

3.1 Past

  • 1CVS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.87%.
  • Measured over the past years, 1CVS shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.20% on average per year.
  • Looking at the last year, 1CVS shows a small growth in Revenue. The Revenue has grown by 6.82% in the last year.
  • The Revenue has been growing slightly by 7.74% on average over the past years.
EPS 1Y (TTM)7.87%
EPS 3Y-13.62%
EPS 5Y-5.2%
EPS Q2Q%46.79%
Revenue 1Y (TTM)6.82%
Revenue growth 3Y8.47%
Revenue growth 5Y7.74%
Sales Q2Q%7.8%

3.2 Future

  • 1CVS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.81% yearly.
  • Based on estimates for the next years, 1CVS will show a small growth in Revenue. The Revenue will grow by 4.65% on average per year.
EPS Next Y23.97%
EPS Next 2Y15.58%
EPS Next 3Y15.17%
EPS Next 5Y13.81%
Revenue Next Year7.59%
Revenue Next 2Y5.06%
Revenue Next 3Y5.17%
Revenue Next 5Y4.65%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1CVS.MI Yearly Revenue VS Estimates1CVS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100B 200B 300B 400B 500B
1CVS.MI Yearly EPS VS Estimates1CVS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.75 indicates a reasonable valuation of 1CVS.
  • 1CVS's Price/Earnings ratio is rather cheap when compared to the industry. 1CVS is cheaper than 81.82% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of 1CVS to the average of the S&P500 Index (28.18), we can say 1CVS is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 10.18, the valuation of 1CVS can be described as very reasonable.
  • 84.85% of the companies in the same industry are more expensive than 1CVS, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 25.51. 1CVS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.75
Fwd PE 10.18
1CVS.MI Price Earnings VS Forward Price Earnings1CVS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, 1CVS is valued a bit cheaper than the industry average as 60.61% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.87
EV/EBITDA N/A
1CVS.MI Per share data1CVS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 1CVS's earnings are expected to grow with 15.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.45
PEG (5Y)N/A
EPS Next 2Y15.58%
EPS Next 3Y15.17%

More info and screens

6

5. Dividend

5.1 Amount

  • 1CVS has a Yearly Dividend Yield of 3.22%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.60, 1CVS pays a better dividend. On top of this 1CVS pays more dividend than 90.91% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.83, 1CVS pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.22%

5.2 History

  • The dividend of 1CVS has a limited annual growth rate of 5.72%.
Dividend Growth(5Y)5.72%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 1CVS pays out 722.81% of its income as dividend. This is not a sustainable payout ratio.
  • 1CVS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP722.81%
EPS Next 2Y15.58%
EPS Next 3Y15.17%
1CVS.MI Yearly Income VS Free CF VS Dividend1CVS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B
1CVS.MI Dividend Payout.1CVS.MI Dividend Payout, showing the Payout Ratio.1CVS.MI Dividend Payout.PayoutRetained Earnings

More info and screens

CVS HEALTH CORP

BIT:1CVS (1/29/2026, 7:00:00 PM)

62.26

-6.14 (-8.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-29
Earnings (Next)02-11
Inst Owners89.6%
Inst Owner ChangeN/A
Ins Owners0.99%
Ins Owner ChangeN/A
Market Cap79.03B
Revenue(TTM)394.08B
Net Income(TTM)469.00M
Analysts80
Price Target80.9 (29.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.22%
Yearly Dividend2.25
Dividend Growth(5Y)5.72%
DP722.81%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.34%
Min EPS beat(2)15.69%
Max EPS beat(2)22.99%
EPS beat(4)4
Avg EPS beat(4)24.17%
Min EPS beat(4)15.69%
Max EPS beat(4)30.76%
EPS beat(8)6
Avg EPS beat(8)6.87%
EPS beat(12)10
Avg EPS beat(12)5.67%
EPS beat(16)14
Avg EPS beat(16)5.3%
Revenue beat(2)2
Avg Revenue beat(2)3.34%
Min Revenue beat(2)3.04%
Max Revenue beat(2)3.64%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-0.46%
Max Revenue beat(4)3.64%
Revenue beat(8)5
Avg Revenue beat(8)0.97%
Revenue beat(12)9
Avg Revenue beat(12)1.97%
Revenue beat(16)13
Avg Revenue beat(16)2.12%
PT rev (1m)4.57%
PT rev (3m)16.14%
EPS NQ rev (1m)0.42%
EPS NQ rev (3m)4.68%
EPS NY rev (1m)0.81%
EPS NY rev (3m)4.44%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)2.27%
Revenue NY rev (1m)0.3%
Revenue NY rev (3m)1.35%
Valuation
Industry RankSector Rank
PE 10.75
Fwd PE 10.18
P/S 0.24
P/FCF 14.87
P/OCF 10.27
P/B 1.28
P/tB N/A
EV/EBITDA N/A
EPS(TTM)5.79
EY9.3%
EPS(NY)6.11
Fwd EY9.82%
FCF(TTM)4.19
FCFY6.72%
OCF(TTM)6.06
OCFY9.73%
SpS262.2
BVpS48.52
TBVpS-25.64
PEG (NY)0.45
PEG (5Y)N/A
Graham Number79.51
Profitability
Industry RankSector Rank
ROA 0.18%
ROE 0.64%
ROCE 6.61%
ROIC 4.9%
ROICexc 5.26%
ROICexgc 19.51%
OM 2.73%
PM (TTM) 0.12%
GM 13.88%
FCFM 1.6%
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
ROICexc(3y)6.76%
ROICexc(5y)6.87%
ROICexgc(3y)25.87%
ROICexgc(5y)25.07%
ROCE(3y)8.35%
ROCE(5y)8.51%
ROICexgc growth 3Y-10.65%
ROICexgc growth 5Y-1.15%
ROICexc growth 3Y-14.28%
ROICexc growth 5Y-4.08%
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-4.91%
F-Score6
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 10.46
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.71%
Interest Coverage -3.53
Cash Conversion N/A
Profit Quality 1341.79%
Current Ratio 0.83
Quick Ratio 0.63
Altman-Z 2.24
F-Score6
WACC8.02%
ROIC/WACC0.61
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.81%
Cap/Sales(5y)0.84%
Profit Quality(3y)191.23%
Profit Quality(5y)191.5%
High Growth Momentum
Growth
EPS 1Y (TTM)7.87%
EPS 3Y-13.62%
EPS 5Y-5.2%
EPS Q2Q%46.79%
EPS Next Y23.97%
EPS Next 2Y15.58%
EPS Next 3Y15.17%
EPS Next 5Y13.81%
Revenue 1Y (TTM)6.82%
Revenue growth 3Y8.47%
Revenue growth 5Y7.74%
Sales Q2Q%7.8%
Revenue Next Year7.59%
Revenue Next 2Y5.06%
Revenue Next 3Y5.17%
Revenue Next 5Y4.65%
EBIT growth 1Y-3.81%
EBIT growth 3Y-12.98%
EBIT growth 5Y-4.24%
EBIT Next Year46.78%
EBIT Next 3Y19.74%
EBIT Next 5Y17.54%
FCF growth 1Y-44.32%
FCF growth 3Y-26.21%
FCF growth 5Y-9.45%
OCF growth 1Y-35.44%
OCF growth 3Y-20.7%
OCF growth 5Y-6.65%

CVS HEALTH CORP / 1CVS.MI FAQ

What is the fundamental rating for 1CVS stock?

ChartMill assigns a fundamental rating of 4 / 10 to 1CVS.MI.


What is the valuation status of CVS HEALTH CORP (1CVS.MI) stock?

ChartMill assigns a valuation rating of 7 / 10 to CVS HEALTH CORP (1CVS.MI). This can be considered as Undervalued.


Can you provide the profitability details for CVS HEALTH CORP?

CVS HEALTH CORP (1CVS.MI) has a profitability rating of 3 / 10.


How financially healthy is CVS HEALTH CORP?

The financial health rating of CVS HEALTH CORP (1CVS.MI) is 3 / 10.


Is the dividend of CVS HEALTH CORP sustainable?

The dividend rating of CVS HEALTH CORP (1CVS.MI) is 6 / 10 and the dividend payout ratio is 722.81%.